Hepatitis C testing and status among opioid substitution treatment clients in New South Wales

Hepatitis C testing and status among opioid substitution treatment clients in New South Wales

Abstract Background: In Australia about half of the people who inject drugs (PWID) are hepatitis C (HCV) antibody positive (anti‐HCV+). The prevalence among opioid substitution treatment (OST) clients specifically is unclear, despite OST clinics being a potential setting for HCV care. This study aim...

Full description

Bibliographic Details
Main Authors: Fiona L. Shand, Carolyn Day, William Rawlinson, Louisa Degenhardt, Nicholas G. Martin, Elliot C. Nelson
Format: Article
Language:English
Published: Elsevier 2014-04-01
Series:Australian and New Zealand Journal of Public Health
Subjects:
hepatitis C virus
HCV
injecting drug users
injecting risks
viral load
Online Access:https://doi.org/10.1111/1753-6405.12173

Internet

https://doi.org/10.1111/1753-6405.12173

Similar Items